153 related articles for article (PubMed ID: 3318557)
21. Responses of serum testosterone levels to human chorionic gonadotrophin stimulation in patients with Klinefelter's syndrome after long-term androgen replacement therapy.
Fukutani K; Ishida H; Shinohara M; Minowada S; Niijima T; Isurugi K
Int J Androl; 1983 Feb; 6(1):5-11. PubMed ID: 6404842
[TBL] [Abstract][Full Text] [Related]
22. Effects of luteinizing hormone-releasing hormone (LRH) upon bioactive and immunoreactive serum LH in patients with Turner's syndrome before and after oestrogen treatment.
Celani MF; Montanini V; Marrama P
Acta Endocrinol (Copenh); 1985 Jul; 109(3):304-8. PubMed ID: 3895799
[TBL] [Abstract][Full Text] [Related]
23. Sex steroid control of gonadotropin secretion in the human male. I. Effects of testosterone administration in normal and gonadotropin-releasing hormone-deficient men.
Finkelstein JS; Whitcomb RW; O'Dea LS; Longcope C; Schoenfeld DA; Crowley WF
J Clin Endocrinol Metab; 1991 Sep; 73(3):609-20. PubMed ID: 1908484
[TBL] [Abstract][Full Text] [Related]
24. Bone mineral density and quantitative ultrasound parameters in patients with Klinefelter's syndrome after long-term testosterone substitution.
van den Bergh JP; Hermus AR; Spruyt AI; Sweep CG; Corstens FH; Smals AG
Osteoporos Int; 2001; 12(1):55-62. PubMed ID: 11305084
[TBL] [Abstract][Full Text] [Related]
25. Endogenous opiates modulate the pulsatile secretion of biologically active luteinizing hormone in man.
Veldhuis JD; Rogol AD; Johnson ML
J Clin Invest; 1983 Dec; 72(6):2031-40. PubMed ID: 6315775
[TBL] [Abstract][Full Text] [Related]
26. A preponderance of circulating basic isoforms is associated with decreased plasma half-life and biological to immunological ratio of gonadotropin-releasing hormone-releasable luteinizing hormone in obese men.
Castro-Fernández C; Olivares A; Söderlund D; López-Alvarenga JC; Zambrano E; Veldhuis JD; Ulloa-Aguirre A; Méndez JP
J Clin Endocrinol Metab; 2000 Dec; 85(12):4603-10. PubMed ID: 11134115
[TBL] [Abstract][Full Text] [Related]
27. Hormonal effects of gonadotropin-releasing hormone (GnRH) agonist in men: effects of long term treatment with GnRH agonist infusion and androgen.
Bhasin S; Yuan QX; Steiner BS; Swerdloff RS
J Clin Endocrinol Metab; 1987 Sep; 65(3):568-74. PubMed ID: 3114307
[TBL] [Abstract][Full Text] [Related]
28. Effects of gonadotropin and testosterone treatments on Lipoprotein(a), high density lipoprotein particles, and other lipoprotein levels in male hypogonadism.
Ozata M; Yildirimkaya M; Bulur M; Yilmaz K; Bolu E; Corakci A; Gundogan MA
J Clin Endocrinol Metab; 1996 Sep; 81(9):3372-8. PubMed ID: 8784099
[TBL] [Abstract][Full Text] [Related]
29. Age-related decrease in hypothalamic gonadotropin-releasing hormone (GnRH) gene expression, but not pituitary responsiveness to GnRH, in the male Brown Norway rat.
Gruenewald DA; Naai MA; Marck BT; Matsumoto AM
J Androl; 2000; 21(1):72-84. PubMed ID: 10670522
[TBL] [Abstract][Full Text] [Related]
30. Endocrine profile in patients with Klinefelter's syndrome.
Hirsch M; Berezin M; Eshkol A; Goldman B; Ovadia J; Lunenfeld B
Arch Androl; 1984; 12(1):103-7. PubMed ID: 6433820
[TBL] [Abstract][Full Text] [Related]
31. The clinical significance of bone mineral density and testosterone levels in Korean men with non-mosaic Klinefelter's syndrome.
Seo JT; Lee JS; Oh TH; Joo KJ
BJU Int; 2007 Jan; 99(1):141-6. PubMed ID: 17092285
[TBL] [Abstract][Full Text] [Related]
32. Potential of testosterone buciclate for male contraception: endocrine differences between responders and nonresponders.
Behre HM; Baus S; Kliesch S; Keck C; Simoni M; Nieschlag E
J Clin Endocrinol Metab; 1995 Aug; 80(8):2394-403. PubMed ID: 7543113
[TBL] [Abstract][Full Text] [Related]
33. Klinefelter's syndrome: effects of short-term testosterone administration on hypothalamic-pituitary axis function.
Forti G; Borghi A; Giusti G; Pazzagli M; Giannotti P; Mannelli M; Fusi S; Serio M
J Endocrinol Invest; 1978 Jul; 1(3):239-44. PubMed ID: 389995
[No Abstract] [Full Text] [Related]
34. LH and FSH response to synthetic LH-RH in children and adolescents with Turner's and Klinefelter's syndrome.
Illig R; Tolksdorf M; Mürset G; Prader A
Helv Paediatr Acta; 1975 Oct; 30(3):221-31. PubMed ID: 1102496
[TBL] [Abstract][Full Text] [Related]
35. Modulation of the gonadotropin response to constant luteinizing hormone-releasing hormone infusion by acute and chronic testosterone administration in Klinefelter's syndrome.
Smals AG; Kloppenborg PW; Pieters GF; Hoefnagels WH; Lequin RM; Benraad TJ
J Clin Endocrinol Metab; 1979 Jan; 48(1):148-52. PubMed ID: 370138
[No Abstract] [Full Text] [Related]
36. Influence of testosterone therapy on clinical and immunological features of autoimmune diseases associated with Klinefelter's syndrome.
Bizzarro A; Valentini G; Di Martino G; DaPonte A; De Bellis A; Iacono G
J Clin Endocrinol Metab; 1987 Jan; 64(1):32-6. PubMed ID: 3097058
[TBL] [Abstract][Full Text] [Related]
37. The effect of short-term testosterone administration on serum FSH, LH and testosterone levels: evidence for selective abnormality in LH control in patients with Klinefelter's syndrome.
Capell PT; Paulsen CA; Derleth D; Skoglund R; Plymate S
J Clin Endocrinol Metab; 1973 Nov; 37(5):752-9. PubMed ID: 4749449
[No Abstract] [Full Text] [Related]
38. High normal testosterone levels in infants with non-mosaic Klinefelter's syndrome.
Aksglaede L; Petersen JH; Main KM; Skakkebaek NE; Juul A
Eur J Endocrinol; 2007 Sep; 157(3):345-50. PubMed ID: 17766718
[TBL] [Abstract][Full Text] [Related]
39. Abnormal melatonin secretion in hypogonadal men: the effect of testosterone treatment.
Luboshitzky R; Wagner O; Lavi S; Herer P; Lavie P
Clin Endocrinol (Oxf); 1997 Oct; 47(4):463-9. PubMed ID: 9404445
[TBL] [Abstract][Full Text] [Related]
40. Testosterone suppresses 8-bromo-adenosine 3',5'-monophosphate and gonadotropin-releasing hormone-stimulated luteinizing hormone subunit synthesis.
Muyan M; Baldwin DM
Endocrinology; 1992 Jun; 130(6):3337-44. PubMed ID: 1597145
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
